Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
| Cas No. | 639052-78-1 |
|---|---|
| Purity | ≥98% |
| Formula | C16H13ClN2OS |
| Formula Wt. | 316.80 |
| IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
| Solubility | 100mM in DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Schulte A, Kolarski D, Sundaram V, et al. Light-control over casein kinase 1delta activity with photopharmacology: a clear case for arylazopyrazole-based inhibitors. Int J Mol Sci. 2022 May 10;23(10):5326. PMID: 35628143.
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Abl inhibitor.
Smoothened agonist.
Quinolone alkaloid precursor of irinotecan, ori...
Synthetic steroid hormone, estrogen analog, use...
Mycotoxin produced by Alternaria; topoisomerase...
Peptide; α4β1 integrin activator.
Corticosteroid
Selective cannabinoid receptor 2 (CB2) inverse ...
H+/K+ ATPase and Scpc phosphatase inhibitor.
Peptide, substance P analog; NK agonist.
Inhibitor of Bcl-2 and Bcl-xL
Viral M2 proton channel blocker, MAO-A, NET, NM...
Statin; HMG-CoA reductase inhibitor, potential ...
ITC, used as chiral agent.
Cyclosporin metabolite; weak calmodulin inhibit...
M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...
Synthetic peptice; μOR agonist.
Mycotoxin derivative; actin polymerization inhi...
Nicotinic acid derivative; InhA inhibitor.
Nitrogen mustard, DNA alkylator.